Yibo Du

406 total citations
11 papers, 320 citations indexed

About

Yibo Du is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yibo Du has authored 11 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Yibo Du's work include Antimicrobial Peptides and Activities (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Ginseng Biological Effects and Applications (1 paper). Yibo Du is often cited by papers focused on Antimicrobial Peptides and Activities (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Ginseng Biological Effects and Applications (1 paper). Yibo Du collaborates with scholars based in China and United States. Yibo Du's co-authors include Shuangshuang Du, Yan Zhao, Guoguang Ying, Jing Ren, Ye Song, Jianxun Wang, Yin Kang, Jack T. Saari, Yan Li and Lu Cai and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and American Journal Of Pathology.

In The Last Decade

Yibo Du

11 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yibo Du China 8 170 42 41 39 33 11 320
Yong-Min Choi South Korea 7 228 1.3× 80 1.9× 13 0.3× 31 0.8× 25 0.8× 11 479
Francisca E. Cara Spain 11 159 0.9× 51 1.2× 21 0.5× 20 0.5× 53 1.6× 15 387
Fernando T. Ogata United States 12 317 1.9× 61 1.5× 44 1.1× 13 0.3× 20 0.6× 17 476
Chiara Ullio Italy 9 300 1.8× 60 1.4× 28 0.7× 9 0.2× 23 0.7× 10 508
Élisabeth Miot-Noirault France 10 157 0.9× 73 1.7× 56 1.4× 8 0.2× 46 1.4× 15 368
Nathan M. Weir United States 7 238 1.4× 46 1.1× 8 0.2× 58 1.5× 52 1.6× 9 442
Xi Su China 12 229 1.3× 101 2.4× 55 1.3× 22 0.6× 16 0.5× 28 454
Kalpana Panati India 12 167 1.0× 25 0.6× 22 0.5× 14 0.4× 12 0.4× 24 386
Yichen Li United States 7 183 1.1× 53 1.3× 20 0.5× 17 0.4× 7 0.2× 12 346
Hyeoncheol Kim United States 6 209 1.2× 80 1.9× 26 0.6× 8 0.2× 21 0.6× 9 434

Countries citing papers authored by Yibo Du

Since Specialization
Citations

This map shows the geographic impact of Yibo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibo Du more than expected).

Fields of papers citing papers by Yibo Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibo Du. The network helps show where Yibo Du may publish in the future.

Co-authorship network of co-authors of Yibo Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yibo Du. A scholar is included among the top collaborators of Yibo Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibo Du. Yibo Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Du, Yibo, Yi Li, Jianhua Gong, et al.. (2021). Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation. Cancer Chemotherapy and Pharmacology. 87(3). 425–436. 14 indexed citations
3.
Du, Yibo, et al.. (2018). Silk fibroin peptide suppresses proliferation and induces apoptosis and cell cycle arrest in human lung cancer cells. Acta Pharmacologica Sinica. 40(4). 522–529. 22 indexed citations
5.
Zhang, Baochun, Jaganathan Lakshmanan, Yibo Du, Jason W. Smith, & Brian G. Harbrecht. (2017). Cell-specific regulation of iNOS by AMP-activated protein kinase in primary rat hepatocytes. Journal of Surgical Research. 221. 104–112. 6 indexed citations
6.
7.
Du, Shuangshuang, et al.. (2017). Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. Journal of Neurochemistry. 144(1). 93–104. 125 indexed citations
8.
Ding, Fengxia, et al.. (2016). BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus. Scientific Reports. 6(1). 38331–38331. 7 indexed citations
9.
Lakshmanan, Jaganathan, Baochun Zhang, Ikenna Nweze, Yibo Du, & Brian G. Harbrecht. (2014). Glycogen Synthase Kinase 3 Regulates IL‐1β Mediated iNOS Expression in Hepatocytes by Down‐Regulating c‐Jun. Journal of Cellular Biochemistry. 116(1). 133–141. 11 indexed citations
10.
Song, Ye, Yibo Du, Sumanth D. Prabhu, & Paul N. Epstein. (2007). Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility. The Review of Diabetic Studies. 4(3). 159–168. 24 indexed citations
11.
Song, Ye, Jianxun Wang, Yan Li, et al.. (2005). Cardiac Metallothionein Synthesis in Streptozotocin-Induced Diabetic Mice, and Its Protection against Diabetes-Induced Cardiac Injury. American Journal Of Pathology. 167(1). 17–26. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026